The convergence of tunable LED lighting technology (module + control) and recent advances in understanding of non-visual neural pathways from eye to brain have created an unprecedented, high-value global market opportunity.
Scientific research has increased our understanding of how non-visual effects of light can be transmitted from the eye to deep structures of the brain involving intrinsically photosensitive Retinal Ganglion Cells (ipRGCs) and other pathways to modulate hormonal secretions and neuronal activity that control health and well-being.
Use of tunable LEDs holds the potential to address a variety medical and well-being conditions that are currently being treated with costly drugs, expensive clinical alternatives, or remain untreated with associated suffering and behavioral dysfunction.
For example, 28 million Americans suffer from migraine headache, equating to nearly 13 per cent of the population, and costing the US economy approximately $13 billion a year.
58% of the US population is estimated to experience insomnia symptoms or sleep disorders that represents a $23.7 billion annual market opporutnity.
The total estimated aggregate market opportunity across three targeted health and wellness sectors (general population, pediatric and youth, geriatric) equals $128.3 billion. Tunable LEDs represent an addressable subset opportunity of $13.6 billion. Even a modest market share of the addressable opportunity represents a significant revenue opportunity for a single company.